>> IRVINE, Calif.--(BUSINESS WIRE)--Oct. 8, 2004-- Allergan, Inc. (NYSE:AGN) announced today that the jury in the Irena Medavoy vs. Arnold Klein, M.D., and Allergan, Inc. lawsuit found that Allergan's product BOTOX® (botulinum toxin type A) was not responsible for the conditions Irena Medavoy alleged she suffered following her treatment with BOTOX® for migraine. The jury trial, which concluded today, was tried in the Superior Court of California, County of Los Angeles, Central District. <<
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”